IGNITE R61/R33 — Assay Development & Neurotherapeutic Screening (No Clinical Trials)
This NINDS IGNITE R61/R33 funding opportunity supports development, optimization, and validation of in vitro/ex vivo/non-mammalian assays and subsequent multi-tier screening to identify small-molecule or biologic neurotherapeutic hits (clinical trials are not allowed). The R61 phase funds feasibility and assay validation, and progression to the R33 for screening and hit characterization requir…
This notice of funding opportunity (NOFO) is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to encourage the translation of research discoveries into new treatments for disorders that fall under the NINDS mission.
This NOFO uses the R61/R33 Phased I…
Funding Source
Awards & funding
Eligibility
Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must be compl…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers